HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Klaus Wethmar Selected Research

Terminator Codon (Termination Codon)

5/2021Somatic Functional Deletions of Upstream Open Reading Frame-Associated Initiation and Termination Codons in Human Cancer.
1/2018Loss-of-function uORF mutations in human malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Klaus Wethmar Research Topics

Disease

4Neoplasms (Cancer)
03/2022 - 01/2018
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 12/2018
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 10/2020
2Residual Neoplasm
01/2022 - 10/2020
2Hodgkin Disease (Hodgkin's Disease)
11/2021 - 01/2021
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
11/2021
1Skin Neoplasms (Skin Cancer)
05/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021
1Lymphoma (Lymphomas)
01/2021
1Multiple Myeloma
01/2021
1Cytokine Release Syndrome
10/2020
1Capillary Leak Syndrome
10/2020
1Disease Progression
10/2020
1Migraine Disorders (Migraine)
12/2019
1Carcinogenesis
01/2018
1Colonic Neoplasms (Colon Cancer)
01/2018
1Acute-Phase Reaction
01/2010

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
03/2022 - 01/2018
2Terminator Codon (Termination Codon)IBA
05/2021 - 01/2018
2blinatumomabIBA
02/2021 - 10/2020
2Inotuzumab OzogamicinIBA
02/2021 - 10/2020
1Peptides (Polypeptides)IBA
03/2022
1Codon (Codons)IBA
03/2022
1HLA Antigens (Human Leukocyte Antigens)IBA
03/2022
1Neoplasm Antigens (Tumor Antigens)IBA
03/2022
1LigandsIBA
03/2022
1LuciferasesIBA
03/2022
1CytokinesIBA
01/2022
1BI 836858IBA
01/2022
1Pharmaceutical PreparationsIBA
10/2020
1Neuropeptide Receptors (Neuropeptide Receptor)IBA
12/2019
1Calcitonin Receptors (Calcitonin Receptor)IBA
12/2019
1GTP-Binding Proteins (G-Protein)IBA
12/2019
1proto-oncogene protein Spi-1IBA
12/2018
1Tyrosine (L-Tyrosine)FDA Link
01/2018
1Phosphotransferases (Kinase)IBA
01/2018
1CCAAT-Enhancer-Binding Protein-betaIBA
01/2010

Therapy/Procedure

4Therapeutics
01/2022 - 01/2021
3Stem Cell Transplantation
11/2021 - 10/2020
2Drug Therapy (Chemotherapy)
01/2022 - 11/2021
2Salvage Therapy
11/2021 - 10/2020
1Aftercare (After-Treatment)
01/2021
1Hematopoietic Stem Cell Transplantation
01/2021
1Hepatectomy
01/2010